|Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the …|
C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ...
Journal of extracellular vesicles 7 (1), 1535750, 2018
|Packaging of prions into exosomes is associated with a novel pathway of PrP processing|
LJ Vella, RA Sharples, VA Lawson, CL Masters, R Cappai, AF Hill
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007
|EVpedia: a community web portal for extracellular vesicles research|
DK Kim, J Lee, SR Kim, DS Choi, YJ Yoon, JH Kim, G Go, D Nhung, ...
Bioinformatics 31 (6), 933-939, 2015
|Inhibition of γ‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes|
RA Sharples, LJ Vella, RM Nisbet, R Naylor, K Perez, KJ Barnham, ...
The FASEB Journal 22 (5), 1469-1478, 2008
|The role of exosomes in the processing of proteins associated with neurodegenerative diseases|
LJ Vella, RA Sharples, RM Nisbet, R Cappai, AF Hill
European Biophysics Journal 37 (3), 323-332, 2008
|Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid|
LJ Vella, DLV Greenwood, R Cappai, JPY Scheerlinck, AF Hill
Veterinary immunology and immunopathology 124 (3-4), 385-393, 2008
|Focus on extracellular vesicles: exosomes and their role in protein trafficking and biomarker potential in Alzheimer’s and Parkinson’s disease|
LJ Vella, AF Hill, L Cheng
International journal of molecular sciences 17 (2), 173, 2016
|C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress|
J Meyerowitz, SJ Parker, LJ Vella, DCH Ng, KA Price, JR Liddell, ...
Molecular neurodegeneration 6 (1), 57, 2011
|MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells|
LJ Vella, A Pasam, N Dimopoulos, M Andrews, A Knights, AL Puaux, ...
Cancer immunology research 2 (4), 351-360, 2014
|The emerging role of exosomes in epithelial–mesenchymal-transition in cancer|
Frontiers in oncology 4, 361, 2014
|Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma|
A Jayachandran, M Anaka, P Prithviraj, C Hudson, SJ McKeown, PH Lo, ...
Oncotarget 5 (14), 5782, 2014
|A rigorous method to enrich for exosomes from brain tissue|
LJ Vella, BJ Scicluna, L Cheng, EG Bawden, CL Masters, CS Ang, ...
Journal of extracellular vesicles 6 (1), 1348885, 2017
|The contribution of tumour-derived exosomes to the hallmarks of cancer|
K Meehan, LJ Vella
Critical reviews in clinical laboratory sciences 53 (2), 121-131, 2016
|Mouse-adapted sporadic human Creutzfeldt–Jakob disease prions propagate in cell culture|
VA Lawson, LJ Vella, JD Stewart, RA Sharples, H Klemm, DM Machalek, ...
The international journal of biochemistry & cell biology 40 (12), 2793-2801, 2008
|BRAF Inhibitor–Driven Tumor Proliferation in a KRAS-Mutated Colon Carcinoma Is Not Overcome by MEK1/2 Inhibition|
MC Andrews, A Behren, F Chionh, J Mariadason, LJ Vella, H Do, ...
Journal of Clinical Oncology 31 (35), e448-e451, 2013
|PrP C-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site|
CL Haigh, VA Lewis, LJ Vella, CL Masters, AF Hill, VA Lawson, SJ Collins
Cell research 19 (9), 1062-1078, 2009
|The Ludwig institute for cancer research Melbourne melanoma cell line panel|
A Behren, M Anaka, PH Lo, LJ Vella, ID Davis, J Catimel, T Cardwell, ...
Pigment cell & melanoma research 26 (4), 597-600, 2013
|The amyloid precursor protein copper binding domain histidine residues 149 and 151 mediate APP stability and metabolism|
L Spoerri, LJ Vella, CLL Pham, KJ Barnham, R Cappai
Journal of Biological Chemistry 287 (32), 26840-26853, 2012
|Identification of a novel amyloid precursor protein processing pathway that generates secreted N‐terminal fragments|
LJ Vella, R Cappai
The FASEB Journal 26 (7), 2930-2940, 2012
|Phosphoproteomic analysis of cell-based resistance to BRAF inhibitor therapy in melanoma|
R Parker, LJ Vella, D Xavier, A Amirkhani, J Parker, J Cebon, MP Molloy
Frontiers in oncology 5, 95, 2015